Icon times
Apollo Hospital Q1FY22 Conference Call Highlights

Apollo Hospital Q1FY22 Conference Call Highlights

Published on 16 August 2021 Views 25 Comments 0

Financial Highlights

  • Apollo Hospitals Enterprise, a healthcare service provider, reported its results for Q1FY22 with an operating revenue of Rs. 3760 Cr, an increase by 73% Y-o-Y compared to Q1FY21 and an increase by 31% Q-o-Q compared to Q4FY21
  • The EBITDA of the company decreased in the quarter to 13.83% from 14.36% in the previous quarter (Q4FY21). Comparison with the corresponding period of previous year (Q1FY21) is not possible because the stringent lockdowns in the country on account of the first wave of the pandemic
  • The PAT of the company in the quarter increased to Rs. 504.83 Cr compared to Rs. 152.77 Cr in the previous quarter – An increase by 230.45% Q-o-Q. The loss in the corresponding quarter of the previous year was Rs. 203.61 Cr
  • During the quarter, the company recorded an exceptional gain of Rs. 294 Cr on remeasurement of previously held equity interest of Gleneagles Development Pte Ltd (a subsidiary) in its joint venture at its fair value post-acquisition of its balance stake
 

Business Highlights

  • At the peak of the covid wave, the company allocated around 5000 beds for covid patients
  • Apollo Hospitals is largest private vaccinator for covid vaccines with 30% of all private vaccinations
  • The company has been able to perform 3.87 million covid vaccinations till date
  • Out of the total hospital revenues, the company has earned Rs. 490 Cr through treatment of Covid-19 patients
  • Apollo 24x7, the company’s online platform has 10 million unique users registered on the platform
  • The company had more than 15000 teleconsultations per day during the peak of the second wave of Covid
  • The company is currently doing 30000 deliveries a day in June 2021 in the pharmacy segment
  • Currently, 5% of the pharmacy revenue is earned through online sales by the company
  • The company acquired 47 lakh new customers during the quarter through either of their segments
  • Tier 2 city hospitals have also performed well during the quarter

 

Future Outlook

  • The company expects margins to increase to around 23% in the future through healthcare services segment
  • Transport and airlines opening up is assuring the company of pent-up demand in the future for elective surgeries and medical tourism. This is a high margin and high APROB business
  • The Apollo brand is very strong and the company expect it to bring a large number of customers especially while expanding to newer cities in the future
  • The margin of newer hospitals can be expected to go up to 20% in the next 3-4 years and mature hospital to go up to 25-26%
Attachments
File Name
private article suscription area icon

You like to know more. We like that!

Please subscribe Model Portfolio Plan to get access of all premium model portfolio articles Only at Rs 7499/Year.

Please login to view this free article.

This blog is available only for logged in users, please register and get access to view this article.

LATEST UPDATE

premium Premium
free Free
Read More

REPORTS


Chat on WhatsApp
Caret UP Arrow
InvestYadnya Support
Typically replies in minutes
InvestYadnya Support
Hi there
Welcome to InvestYadnya.
We are available to assist you on WhatsApp.
Please click on the button below to chat with us.
(10 AM to 7 PM IST)
16:10
Chat with InvestYadnya